Safe Implementation of Thrombolysis in Stroke - Monitoring Study
NCT02229812 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6475
Last updated 2014-09-01
Summary
Study to evaluate the safety and efficacy of intravenous alteplase within 3 hours of symptom onset in acute ischemic stroke patients
Conditions
Interventions
- DRUG
-
alteplase
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-12-31
- Primary Completion
- 2006-07-31
More Related Trials
-
EXtending the tIme Window of Thrombolysis by ButyphThalide up to 6 Hours After Onset (EXIT-BT)
NCT05189509 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
NCT06115070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
NCT03394950 ·Status: COMPLETED ·Phase: PHASE4
-
Thrombectomy Under Reopro Versus Alteplase to Treat Stoke
NCT02016547 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT
NCT05198323 ·Status: RECRUITING ·Phase: PHASE2
-
Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China（IVTIS）
NCT06131385 ·Status: RECRUITING
-
Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
NCT03661411 ·Status: COMPLETED ·Phase: PHASE4
-
Multi-arm Optimization of Stroke Thrombolysis
NCT03735979 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)
NCT05193071 ·Status: COMPLETED ·Phase: PHASE4
-
Antiplatelet Therapy for AIS Patients With Thrombocytopenia
NCT06053021 ·Status: RECRUITING ·Phase: NA
-
Alteplase Treatment in Elderly Acute Ischaemic Stroke (AIS) Patients
NCT05401149 ·Status: COMPLETED
-
24 Hours Treatment with Alteplase in Patients with Ischemic Stroke
NCT04879615 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window
NCT05752916 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of Intravenous Thrombolysis for Wake-up Stroke
NCT01183533 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke
NCT06768138 ·Status: RECRUITING ·Phase: PHASE3
-
Endovascular Therapy for Acute Ischemic Stroke Trial
NCT02350283 ·Status: COMPLETED ·Phase: PHASE3
-
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）
NCT05281549 ·Status: UNKNOWN ·Phase: PHASE2
-
Alteplase in Elderly Acute Ischemic Stroke (AIS) Patients During Hospitalization
NCT05395351 ·Status: COMPLETED
-
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke
NCT00790920 ·Status: COMPLETED ·Phase: PHASE3
-
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）
NCT05745259 ·Status: UNKNOWN ·Phase: PHASE3
-
THE IMPACT- 24M TRIAL (IMPlant Augmenting Cerebral Blood Flow in Mild Strokes Trial 24 Hours From Stroke Onset)
NCT03551093 ·Status: COMPLETED ·Phase: NA
-
Stroke Treatment With Acute Reperfusion and Simvastatin
NCT01073007 ·Status: COMPLETED ·Phase: PHASE4
-
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
NCT00784134 ·Status: COMPLETED ·Phase: PHASE3
-
Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis
NCT07347626 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3